Indication
Hyperprolactinemia
Hyperprolactinemia is an endocrine disorder characterized by abnormally elevated circulating levels of prolactin, a polypeptide hormone synthesized and secreted by the anterior pituitary gland. Read more about Hyperprolactinemia
28 drugs 24 manufacturers
Drugs that treat it
Common Hyperprolactinemia therapies.
BROMOCRIPTINE MESYLATE
CABERGOLINE
CABERGOLINE
CABERGOLINE
BROMOCRIPTINE MESYLATE
BROMOCRIPTINE MESYLATE
BROMOCRIPTINE MESYLATE
BROMOCRIPTINE (bromocriptine mesylate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHyperprolactinemia is an endocrine disorder characterized by abnormally elevated circulating levels of prolactin, a polypeptide hormone synthesized and secreted by the anterior pituitary gland.
Pathophysiologically, the condition commonly arises from prolactin-secreting pituitary adenomas (prolactinomas), loss of hypothalamic dopaminergic inhibition due to stalk disruption or dopamine receptor antagonist medications, primary hypothyroidism, or renal clearance impairment.
Elevated prolactin suppresses hypothalamic gonadotropin-releasing hormone pulsatility, resulting in hypogonadism and reproductive dysfunction across both sexes.
Clinical manifestations typically include galactorrhea, oligomenorrhea, amenorrhea, and infertility in females, as well as decreased libido, erectile dysfunction, gynecomastia, and subfertility in males.
- nih.gov
Hyperprolactinemia is an endocrine disorder characterized by abnormally elevated circulating levels of prolactin, a polypeptide hormone synthesized and secreted by the anterior pituitary gland Pathophysiologically, the condition commonly arises from prolactin-secreting pituitary adenomas (prolactinomas), loss of hypothalamic dopaminergic inhibition due to stalk disruption or dopamine receptor antagonist medications, primary hypothyroidism, or renal clearance impairment Elevated prolactin suppres...
- nih.gov
Hyperprolactinemia is an endocrine disorder characterized by abnormally elevated circulating levels of prolactin, a polypeptide hormone synthesized and secreted by the anterior pituitary gland
- nih.gov
Pathophysiologically, the condition commonly arises from prolactin-secreting pituitary adenomas (prolactinomas), loss of hypothalamic dopaminergic inhibition due to stalk disruption or dopamine receptor antagonist medications, primary hypothyroidism, or renal clearance impairment
- endocrine.org
Elevated prolactin suppresses hypothalamic gonadotropin-releasing hormone pulsatility, resulting in hypogonadism and reproductive dysfunction across both sexes Clinical manifestations typically include galactorrhea, oligomenorrhea, amenorrhea, and infertility in females, as well as decreased libido, erectile dysfunction, gynecomastia, and subfertility in males
Personalize your experience
Follow Hyperprolactinemia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.